Injectable Generic Drugs Presents a Host of Opportunities

The area of injectable generic drugs presents a host of opportunities for industry planners and venture capitalists. Health payers have been moving towards generic substitution and this combined with low commercialization of new drugs has enabled this market to register double digit growth. Most of the growth has been witnessed in mainstream drugs coupled with tablet administration and with oversupply in some areas this has led to falling margins for the generic companies. The business of injectable generic business has bypassed this trend as very few companies are producing injectables but this coupled with high prices and the market opportunities presented is expected to increase its attractiveness to a number of companies.

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>